| 10.34 0.09 (0.88%) | 11-05 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.49  |
1-year : | 12.83 |
| Resists | First : | 10.69 |
Second : | 10.98 |
| Pivot price | 10.3 |
|||
| Supports | First : | 10.22 | Second : | 8.5 |
| MAs | MA(5) : | 10.26 |
MA(20) : | 10.34 |
| MA(100) : | 11.44 |
MA(250) : | 0 | |
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 26 |
D(3) : | 16.1 |
| RSI | RSI(14): 38.6 |
|||
| 52-week | High : | 23.76 | Low : | 9.98 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ JATT ] has closed below upper band by 32.8%. Bollinger Bands are 85.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 10.35 - 10.42 | 10.42 - 10.48 |
| Low: | 10.14 - 10.21 | 10.21 - 10.28 |
| Close: | 10.24 - 10.36 | 10.36 - 10.45 |
JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses. The company was incorporated in 2026 and is based in Westfield, New Jersey.
Wed, 16 Sep 2026
Someit Sidhu Discloses Investment at JATT II Acquisition Corp. with 23.1% Stake - TradingView
Wed, 26 Aug 2026
JATT mastermind launches latest biotech-focused SPAC via $60M IPO - Fierce Biotech
Wed, 26 Aug 2026
Jatt III Acquisition Prices $60 Million IPO - Yahoo Finance
Tue, 25 Aug 2026
JATT III Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering - Yahoo Finance
Thu, 13 Aug 2026
JATT II Acquisition Corp. 1H 2026: Net loss $(374K), EPS $(0.09) — 10-Q Summary - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 8 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 26.9 (%) |
| Held by Institutions | 69.9 (%) |
| Shares Short | 6 (K) |
| Shares Short P.Month | 11 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.08 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -129.25 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|